Find Academic Supervisors

Peter HuxleyView profile

Professor

• Mental Health
• Social Inclusion
• Quality of Life
• +8 more

Peter Huxley is a Professor of Mental Health Research and Chair in Mental Health Research at the School of Health Sciences, Bangor University. His work focuses on mental health, social inclusion, quality of life, and healthcare integration. He leads several research projects addressing gaps in mental health services, including collaborative care models (e.g., PARTNERS2), the digital divide among individuals with severe mental illness, and social prescribing policies. His research spans global health contexts, with studies in low- and middle-income countries such as Sri Lanka and Hong Kong. Key research interests include self-harm prevention, mental health policy, and cross-cultural measurement of social inclusion using tools like the Social & Community Opportunities Profile (SCOPE). He has led over 30 international projects, including studies on healthcare pathways (Goldberg-Huxley model), economic evaluations, and mindfulness interventions for care home staff in Wales. Projects: "In Wales, are contemporary models of front-line social care for people with recurrent mental ill health fit for purpose?" (2023–2027) "Improvement and innovation in public mental health services care delivery using a new digital platform (DIALOG+)" (2023–2024) "Is there a Covid psychosis?" (2020–2021) Collaborations: Partnerships in Hong Kong, Poland, Brazil, and Sri Lanka, focusing on mental health equity and service integration. Grants: Multiple UK and international grants supporting his work on social inclusion, healthcare policy, and digital health. Huxley’s work aligns with UN Sustainable Development Goals, particularly those addressing health and well-being (Goal 3) and reducing inequalities (Goal 10). His research outputs emphasize translating findings into actionable policies and service improvements.

• Developmental Psychology
• Family Psychology
• Child Mental Health
• +6 more

Professor Bonamy Oliver is a Professor of Developmental and Family Psychology at University College London's IOE - Faculty of Education and Society, leading the Mental Health, Wellbeing and Education Network. Her research focuses on children’s mental health, family relationships, and behavioral genetics. She developed the ESO observation tool, enabling remote parent-child interaction assessments, now used globally. She holds a prestigious 2023 ACAMH Impact Award and contributes to NICE guidelines. Academic roles include Associate Professor (2020-2024) and promoted to full Professor in 2024. She chairs IOE’s Mental Health and Wellbeing Network and directs NurtureLab. Education: PhD in Psychology and Behavioural Genetics (King’s College London, 2006), postdoctoral training at King’s College, followed by faculty roles at Sussex and Goldsmiths. Collaborations span UCL’s Institute of Mental Health, ICH GOS Mental Health Strategic Initiative, and the Accessible Genetics Consortium. Research interests include genetic influences on child development, intervention efficacy, and bridging academic-practitioner gaps. Recent work emphasizes mindful parenting, sibling dynamics, and resilience mechanisms. Articles (2024–2025) address parent-child relationships, polygenic scores in psychopathology, and cross-cultural studies of household chaos. Awards: ACAMH Impact Award (2023), NICE Guidelines contributor Leadership: Chair of IOE’s Mental Health Network, Director of NurtureLab Key Projects: ESO tool, CoTEDS children-of-twins study Advising and grants include interdisciplinary collaborations on child mental health interventions. Labs/Teams: NurtureLab at UCL, cross-institutional mental health initiatives.

Evelyn ChoView profile

Assistant Professor

• Clinical Psychology
• Mental Health Services
• Youth Mental Health
• +3 more

Evelyn Cho is an Assistant Professor at the University of Oregon, jointly affiliated with the Ballmer Institute for Children’s Behavioral Health and the Department of Psychology's clinical area. Her research focuses on improving youth mental health service access through dissemination and implementation of evidence-based practices (EBPs). Ballmer Institute faculty member Recipient of grants from Inequality in America Initiative and AIM Youth Mental Health Research interests span three key areas: Examination of EBP implementation by community mental health providers Identification of factors enabling effective EBP delivery Development of clinician support tools for implementation enhancement Recent publications analyze EBP adoption patterns, organizational influences on standardized assessments, and strategies for integrating evidence-based approaches into routine youth mental health services. Her work combines clinical expertise with implementation science to bridge research-practice gaps in pediatric mental healthcare. Scientific contributions recognized through: Inequality in America Initiative funding AIM Youth Mental Health support

Jan BergströmView profile

Assistant Professor

• Clinical Psychology
• Cognitive Behavioral Therapy (CBT)
• Digital Psychological Interventions
• +9 more

Jan Bergström is Assistant Professor of Clinical Psychology at Stockholm University's Department of Psychology, where he serves as Director of Studies for the Postgraduate Psychotherapist Program and Head of the Stockholm University Psychology Clinic. His research focuses on self-help based CBT and digital psychological interventions, with particular emphasis on clinical behavior analysis, psychotherapy supervision, Behavioral Activation for depression, exposure-based interventions for anxiety/OCD, and Functional Analytic Psychotherapy (FAP). He also investigates metatheoretical aspects of psychotherapy and mental health treatment mechanisms. Research group: Clinical psychology, neuroscience and health Key clinical interests: Mental health problems in neurodiverse populations (autism, ADHD) His publications demonstrate extensive work on internet-delivered therapies for panic disorder, OCD, and depression, including comparisons of blended vs full treatment modalities. He has developed non-heteronormative psychometric instruments like the revised Social Interaction Anxiety Scale (SIAS). Current projects include ZeroOCD smartphone app development for OCD treatment and iMERAT emotion recognition training for adolescents. The academic literature shows his focus on treatment efficacy, therapist time optimization (47% reduction in blended models), and functional analytic approaches to mental health classification. His cross-disciplinary work combines psychological theory with technology-mediated solutions, bridging clinical practice, neuroscience, and digital health innovations.

Kevin PanView profile

Associate Professor

• Business Analytics
• Data Analytics in Finance
• Data Analytics in Accounting
• +5 more

Kevin Pan is an Associate Professor of Quantitative Analysis at Samford University’s Brock School of Business, where he teaches and researches at the intersection of business analytics, finance, accounting, management, healthcare, education, and Christian faith integration. Education Ph.D. in Biomedical Informatics, Stanford University M.S. in Electrical Engineering, Stanford University B.S. in Electrical Engineering (minor Mathematics), National Taiwan University Research Interests Dr. Pan’s work centers on leveraging data analytics to solve real-world problems in business and society. He explores financial fraud detection, corporate social responsibility, healthcare quality, and the ethical implications of data-driven decision making. A distinctive thread in his scholarship is the integration of Christian worldview with business analytics education and practice. Publication Trends His recent articles (2017-2023) reveal a dual focus: methodological contributions in data visualization and analytics education, and applied studies addressing opioid prescribing, hospital fraud, congregational fraud, and pandemic ethics. The work spans accounting, finance, healthcare, pharmacy, and business ethics journals. Service & Outreach He actively volunteers with Hope Heals , a Christian disability ministry founded by Samford alumni, and participates in local church activities in Birmingham, Alabama.

Md Mobashir Hasan ShandhiView profile

Assistant Professor

• Digital health technologies
• Wearable sensors
• Machine learning algorithms
• +10 more

Md Mobashir Hasan Shandhi is a tenure-track Assistant Professor at Arizona State University , jointly appointed in the School of Electrical, Computer and Energy Engineering and the Biodesign Institute Center for Bioelectronics and Biosensors . His work focuses on developing equitable digital health technologies—wearable sensors and AI/ML algorithms—for personalized care and remote monitoring of chronic and infectious diseases. Education PhD, Electrical and Computer Engineering, Georgia Institute of Technology, 2020 Postdoc, Biomedical Engineering, Duke University, 2021–2024 MS, Electrical and Computer Engineering, University of Utah, 2016 BSc, Electrical and Electronics Engineering, Bangladesh University of Engineering and Technology, 2011 Research Interests Dr. Shandhi’s lab designs low-cost, reliable wearable sensors and machine-learning models to enable remote monitoring of cardiovascular, respiratory, and infectious disease patients. His goal is to reduce healthcare disparities by translating these technologies into resource-limited settings. Scientific Awards & Grants American Heart Association Career Development Award Mayo Clinic–ASU Alliance Faculty Summer Residency Fellowship AHA Postdoctoral Fellowship Duke Heart Center & Translating Duke Health cardio-oncology grant NIH mHealth Training Institute Scholarship Best Paper, Runner-up Best Paper, First Place Research Awards Distinguished Poster Nominee Advising & Funding Dr. Shandhi is currently recruiting PhD students with backgrounds in electrical/biomedical engineering or computer science. He also welcomes postdocs and MS/undergraduate researchers to join the SHANDHI Lab. Interested candidates should email him directly with a CV and statement of interest. Labs & Teams He directs the SHANDHI Lab at ASU, where interdisciplinary teams of engineers, clinicians, and data scientists collaborate on translating wearable health technologies from bench to bedside.

Diana M. FalkenbachView profile

Associate Professor

• Psychopathy
• Aggression
• Forensic Psychology
• +5 more

Dr. Diana M. Falkenbach is a tenured Associate Professor in the Psychology Department at John Jay College of Criminal Justice, City University of New York (CUNY), and Director of the M.A. program in Forensic Psychology. She holds a PhD in Clinical Psychology from the University of South Florida, an MS in Counseling from Georgia State University, and a BA in Psychology from Emory University. Her research focuses on psychopathy, aggression, and assessment methodologies, with special attention to diverse populations including women, juveniles, and noncriminal groups. Current projects explore psychopathic traits in police, FBI, and corporate settings. She has contributed to peer-reviewed journals and authored chapters in forensic psychology and criminology. Education : PhD in Clinical Psychology, University of South Florida (2004) MS in Counseling, Georgia State University (1996) BA in Psychology, Emory University (1994) Research Interests : Dr. Falkenbach’s work examines the etiology of psychopathy, aggression, and the development of assessment tools. She investigates psychopathic traits in understudied groups, including women and juveniles, and explores the overlap between criminal psychopathy and “successful” adaptations in professions like policing and corporate roles. Her recent studies address cross-cultural variations in psychopathy and the validity of aggression assessment instruments. Publications : Over 15 peer-reviewed articles and book chapters since 2001, focusing on psychopathy subtypes, forensic assessment, and aggression. Key themes include psychopathy’s relationship with professional success, emotional intelligence, and malingering in criminal defendants. Labs/Teams : Directs the M.A. program in Forensic Psychology at John Jay, fostering graduate training in forensic research and clinical practice.

• Adolescent Health
• Young Adult Oncology
• Mental Health Services
• +6 more

Sharon Medlow is a Principal Research Fellow at the Specialty of Child and Adolescent Health, University of Sydney, and serves as Research Translation Coordinator for the Wellbeing Health & Youth (WH&Y) NHMRC Centre of Research Excellence. Her work focuses on adolescent and young adult (AYA) health services, including mental health, cancer care, and transition from pediatric to adult care. She has pioneered research on marginalized youth health, digital health innovations, and healthcare system improvements. Her role involves coordinating research translation, mentoring early-career researchers, and fostering interdisciplinary collaborations. Her research emphasizes service development for vulnerable populations, with a particular focus on emergency department interventions, virtual reality applications in healthcare, and mobile health technologies. Medlow has conducted systematic reviews on puberty tempo impacts, FASD, and transition care guidelines. She has also explored the health needs of homeless youth and parenting interventions for adolescents with behavioral challenges. Medlow's publications span topics like emergency mental health interventions, VR-based distress management, and implementation science in adolescent care. While no formal awards are listed, her contributions to AYA health research have significantly influenced clinical practice and policy in Australia. She leads WH&Y's translational research initiatives, integrating young people’s perspectives into health systems design. Her work bridges clinical practice and research, aiming to improve healthcare accessibility and quality for adolescents globally.

• Medical Devices
• Biomedical Engineering
• Wireless Healthcare Technology
• +4 more

John S. Y. Ho is an Associate Professor in the Department of Electrical and Computer Engineering at the National University of Singapore. His research focuses on developing wireless medical devices for real-time monitoring and intervention in treatment-resistant medical conditions. Notably, he has pioneered work on vagus nerve stimulation (VNS) for depression and digital therapeutics. Ho holds a PhD in electrical engineering from Stanford University, where he was a National Defense Science and Engineering Graduate Fellow. Professional accolades include the NRF Fellowship, NUS Young Investigator Award, and recognition on MIT TR35 and Forbes 30 Under 30 Asia lists. His interdisciplinary work bridges engineering and medicine, addressing gaps in mental health treatment through innovative technologies. Education: PhD in Electrical Engineering, Stanford University Research interests center on neurostimulation therapies, depression biomarkers, and clinical outcome measurement. Key projects include large-scale trials evaluating VNS efficacy and digital tools like CT-152 for treatment-resistant depression. His work emphasizes translational research to improve patient care and reduce treatment resistance. Publications highlight advancements in antidepressant pharmacology, metabolomics, and suicide risk assessment. Ho collaborates globally on initiatives like the RECOVER trial (VNS efficacy) and TX-YDSRN (adolescent mental health). Current efforts focus on deploying AI-driven tools for mental health monitoring and optimizing measurement-based care in primary settings. No specific grants or labs are explicitly mentioned in the text.

• Neuroscience
• Neonatology
• Developmental Psychology
• +7 more

Efthymios Papatzikis is a Professor of Infant Brain Development at Oslo Metropolitan University’s Faculty of Education and International Studies. He leads the Advanced Health Intelligence and Brain-Inspired Technologies (ADEPT) Research Group, focusing on brain development in the first 1500 days of life using neuroimaging, behavioral analysis, and AI-driven tools. Research Focus: Multimodal neuroimaging (qEEG, ABR, aEEG), computational neuroscience, AI in NICU diagnostics, and personalized sound/music interventions. Collaborations: Harvard University, Martinos Center for Biomedical Imaging, UCL, and Bergen University. Editorial Roles: Associate Editor for Frontiers in Pediatric Psychology, Guest Editor for Frontiers in Pediatric Neurology. His work bridges neuroscience with clinical neonatal care, emphasizing family-centered medicine and precision diagnostics. Recent projects include EU Cost Action CA22111 on real-world environments’ impact on brain development. Scientific Awards: Fellow of the Higher Education Academy (FHEA), UK Certified Specialist in Social Prescribing by the World Health Organization He contributes to journals as reviewer and editor, co-develops computational tools for NICU EEG analysis, and advises international foundations on maternal/child health and early childhood education.

• Critical Care Medicine
• Risk Prediction in ICU
• Chronic Critical Illness
• +4 more

Jason Shahin is an Assistant Professor at the Department of Medicine , Faculty of Medicine and Health Sciences , McGill University . He serves as an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) , specifically within the Translational Research in Respiratory Diseases Program . His academic and clinical work bridges critical care medicine and respiratory medicine at the McGill University Health Centre (MUHC) . Research Focus: Dr. Shahin specializes in risk prediction in intensive care units (ICU) , with particular emphasis on prediction tools for complex populations , including the chronic critically ill and potential organ donors . His work integrates clinical data science with translational approaches to improve ICU outcomes. Article Trends: His publications span critical care medicine , sepsis , mechanical ventilation , and organ donation . Recent studies focus on machine learning applications , probiotics in infection prevention , and blood conservation strategies in ICU settings. Key Collaborations: He contributes to large-scale trials like the LOVIT , PROSPECT , and FORECAST studies, collaborating with networks such as the Canadian Critical Care Trials Group and REVA Network .

Colleen LooView profile

Professor

• Electroconvulsive Therapy
• Transcranial Magnetic Stimulation
• Transcranial Direct Current Stimulation
• +7 more

Professor Colleen Loo, MBBS (Hons), FRANZCP, MD (research doctorate), is a clinical psychiatrist and Professor of Psychiatry at the University of New South Wales and the Black Dog Institute in Sydney, Australia. She is an internationally recognized clinical expert and researcher in electroconvulsive therapy (ECT), Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), and ketamine, having led the first Australian RCTs of these interventions in depression. With over 300 peer-reviewed publications, she has established herself as a leading authority in interventional psychiatry. Professor Loo's research expertise spans multiple domains of neuromodulation and novel psychiatric treatments. Her team at UNSW, based at the Black Dog Institute, focuses on transcranial magnetic stimulation, transcranial direct current stimulation, ECT, ketamine, and psychedelics. Current research streams include clinical trials of novel treatments for depression and anorexia, experiments improving brain stimulation approaches, cognitive neuroscience using brain stimulation to enhance cognition, combining brain stimulation with neuroimaging techniques, real-world treatment data collection through the CARE network, and computational modeling of brain stimulation effects. Her work bridges fundamental neuroscience with practical clinical implementation across diverse patient populations. Analysis of Professor Loo's recent publication record reveals a strong emphasis on advancing clinical applications of neuromodulation techniques, with particular focus on ketamine therapy (especially through the KADS trial), ECT optimization, and expanding applications across different demographic groups including the elderly. Her work spans from fundamental biological mechanisms to economic evaluations and real-world implementation challenges. Grant funding from Australian NHMRC Grant funding from MRFF Grant funding from US-based NARSAD and Stanley Foundations Grant funding from UK NHS/MRC Grant funding from Singapore NMC Grant funding from Ramsay Hospital Research Foundation Professor Loo has established clinics for novel treatments for depression (TMS, ketamine, tDCS) at the Black Dog Institute and Ramsay Clinic Northside, Sydney. She has developed professional training courses for psychiatrists in ECT, TMS, tDCS, and ketamine, and serves as an expert adviser to Australian government health departments and the Royal Australian and New Zealand College of Psychiatrists. She is the first person outside North America to become President of the International Society for ECT and Neurostimulation (ISEN). Professor Loo leads the Neurostimulation & Interventional Psychiatry Team at the Black Dog Institute and co-founded the Clinical Alliance and Research in ECT and Related Treatments (CARE) network, which collects real-world treatment data to improve clinical practice in neurostimulation and interventional psychiatry across multiple international sites.

Kate BakerView profile

Assistant Professor

• Neurodevelopmental Disorders
• Clinical Genetics
• Cognitive Neuroscience
• +3 more

Dr. Kate Baker is a Programme Leader at the MRC Cognition and Brain Sciences Unit, University of Cambridge, and holds joint appointments as Assistant Professor of Clinical Genetics in the Department of Pathology and Honorary Consultant at Cambridge University Hospital. Her research bridges clinical genetics and cognitive neuroscience, focusing on neurodevelopmental disorders of genetic origin. She leads the Genomic Disorders and Cognitive Development group and the BINGO project, investigating how genetic variations impact neural systems and cognitive abilities like communication and social interaction. Her work emphasizes translational genomic medicine, aiming to improve evidence-based, person-centered care for individuals with intellectual disabilities. Research spans neurogenetics, cognitive phenotyping, synaptic function, and developmental trajectories. Publications consistently explore genotype-phenotype correlations in disorders like SYT1, ZDHHC9, and DDX3X, with recent work expanding into pandemic impacts on neurogenetic families. Key funders include the Baily Thomas Charitable Trust, NIHR Cambridge Biomedical Research Centre, and Great Ormond Street Hospital Charity. No awards are documented in available sources.

Michael NothnagelView profile

Professor

• Statistical Genetics
• Genetic Epidemiology
• Population Genetics
• +5 more

Michael Nothnagel is a Professor at the University of Cologne, where he leads the Department of Statistical Genetics and Bioinformatics within the Cologne Center for Genomics (CCG). His work spans statistical genetics, genetic epidemiology, and forensic genetics, focusing on methodological development and large-scale genomic data analysis. His research interests encompass theoretical and applied statistical genetics, with emphasis on human genetic diversity, disease etiology, and forensic applications. Key areas include Y-chromosomal phylogeography, genome-wide association studies for complex diseases, development of statistical methods for variant interpretation, and forensic marker optimization. His group leverages next-generation sequencing data and specialized forensic markers to address questions in population history, disease mechanisms, and identification systems. Recent publications reveal a strong focus on computational approaches to genetic analysis, including spatial frequency interpolation for haplogroup mapping, polygenic risk score applications for behavioral traits, and advanced methods for variant classification. His work demonstrates consistent integration of statistical theory with practical applications in medical and forensic genetics, often through international collaborations like the VISAGE Consortium. Nothnagel maintains active involvement in the Cologne Center for Genomics, contributing to seminars and collaborative projects including the upcoming 34th International Genetic Epidemiology Society meeting. His research group operates at the intersection of computational biology and medicine, with particular strengths in handling complex genomic datasets and developing novel analytical frameworks for genetic epidemiology.

Adrian RaineView profile

Professor

• Neurocriminology
• Biological Basis of Antisocial Behavior
• Psychopathy
• +6 more

Adrian Raine is a Professor at the University of Pennsylvania, holding joint appointments in the Departments of Criminology, Psychiatry, and Psychology. He is renowned for pioneering Neurocriminology, a discipline integrating neuroscience with criminological inquiry. His research focuses on biological underpinnings of antisocial behavior, including psychopathy, aggression, and violence. Raine directs the Mauritius Child Health Project, a 50+ year longitudinal study examining child development and health impacts on antisocial outcomes. He earned his B.A., M.A., and D.Phil. in Experimental Psychology from Oxford University and York University. His work employs advanced techniques like structural/functional brain imaging, neuroendocrinology, and transcranial stimulation. Key areas include nutritional interventions (e.g., omega-3 and vitamin D supplementation), autonomic nervous system functioning, and the biopsychosocial model of criminality. Raine's research highlights biological risk factors like low resting heart rate, diminished empathy, and brain abnormalities. He advocates for neuroscience-informed penal policies, emphasizing prevention over punishment. Recent studies explore bidirectional relationships between sleep quality and child behavior, as well as cross-cultural psychopathology patterns. Lab Focus: Biological interventions, antisocial behavior, and neurocriminology Key Projects: Mauritius Child Health Project, ABCD Study collaborations Techniques: fMRI, EEG, nutritional trials, behavioral assessments He develops validated clinical tools like the Schizotypal Personality Questionnaire (SPQ), Reactive-Proactive Aggression Questionnaire (RPQ), and Selfishness Scale (SQ). His work bridges basic science and practical applications in criminal justice and mental health systems.